Importance of screening and confirmatory tests to detect blood donors infected by the hepatitis C virus;Importância dos testes sorológicos de triagem e confirmatórios na detecção de doadores de sangue infectados pelo vírus da hepatite C

Revista Brasileira de Hematologia e Hemoterapia

Volumn 30, Issue 3, 2008, Pages 218-222

  Garcia, Fernanda B ^a   Gomide, Geisa P M ^a   Pereira, Gilberto A ^b   Moraes Souza, Helio ^a,c  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UFTM

^c NONE   (Brazil)

Author keywords

Blood donors; Confirmatory test; Hepatitis C; Serological screening

Indexed keywords

EID: 54949096180     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842008000300011     Document Type: Article

References (27)

1. Ministério da Saúde. Brasil. Portaria no 1.376, de 19 de novembro de 1993. Publicada no Diário Oficial da União em 02/12/1993. Disponível em: http://e-legis.anvisa.gov.br - acesso em 12 abr 2006.
2. Fundação Hemominas. Boletim estatístico anual - 1998. Divisão de Apoio Técnico da Fundação Hemominas: Belo Horizonte/MG.
3. Ministério da Saúde. Agência Nacional de Vigilância Sanitária (Anvisa). Resolução RDC no 153, de 14 de junho de 2004. Publicada no Diário Oficial da União de 24 de junho de 2004. Disponível em: http://e-legis.anvisa.gov.br - acesso em 12 abr 2006.
4. Department of Clinical Epidemiology and Biostatistics of McMaster University Health Sciences Center (DCEB). How to read clinical journals: To learn about a diagnostic test. Can Med Assoc J. 1981;124:703-751.
5. Prohaska W, Schroeter E, Kaars-Wiele P et al. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests. Eur J Clin Chem Clin Biochem. 1992;30(7):397-404.
6. Kim YS, Lee HS, Ahn YO. Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR. J Korean Med Sci. 1999;14(6):629-34.
7. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet. 1990;336(8719):878-9.
8. Weiner A, Houghton M, Han J et al. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991;14(2):381-8
9. Salles NA, Sabino EC, Barreto CC et al. The discarding of blood units and the prevalence of infectious disease in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Rev Panam Salud Publica. 2003;13(2-3):111-6.
10. Ministério da Saúde. Agência Nacional de Vigilância Sanitária (Anvisa). Relatório da produção hemoterápica do estado de Minas Gerais de 2000 a 2002. Disponível em: http://www.anvisa.gov.br - acesso em 05 mar 2006.
11. Brandão AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol. 2002;2:18.
12. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36(5 Suppl 1):S21-9.
13. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006;13(1):34-41.
14. Otani MM, Salles NA, Barreto AM et al. Evaluation of the concomitant use of two different EIA tests for HIV screening in blood banks. Rev Panam Salud Publica. 2003;13(2-3):172-5.
15. Valente VB, Covas DT, Passos AD. Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center. Rev Soc Bras Med Trop. 2005;38(6):488-92.
16. Tucker TJ, Voigt M, Bird A et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - comparison of screening tests and PCR. S Afr Med J. 1997;87(5):603-5.
17. Amorim RM, Oliveira CP, Wyant PS et al. Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz. 2004;99(8):895-7.
18. Martins RM, Teles SA, Freitas NR et al. Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(1):53-5.
19. Gretch DR. Use and interpretation of HCV diagnostic tests in the clinical setting. Clin Liver Dis. 1997;1(3):43-557.
20. Krajden M. Hepatitis C virus diagnosis and testing. Can J Public Health. 2000;91 Suppl 1:S34-9, S36-42.
21. Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays. Vox Sang. 2007;92(4):297-301.
22. Kao JH, Lai MY, Chen PJ et al. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis. Am J Gastroenterol. 1996;91(3):506-10.
23. Zhang HQ, Wang GH, Chen K, Xiu BS, Song XG, Liu HZ et al. Studies on the correlation between titer of antibodies against different function regions of hepatitis C virus and HCV RNA of chronic patients. Chinese Journal of Hepatol. 2003;11(12):754-5.
24. Busch MP, Glynn SA, Stramer SL et al. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006;46(3):469-75.
25. Cleary PD, Van Devanter N, Rogers TF et al. Depressive symptoms in blood donors notified of HIV infection. Am J Public Health. 1993;83(4):534-9.
26. Busch MP. To thy (reactive) donors be true! Transfusion. 1997;37(2):117-20.
27. Dodd RY, Stramer SL. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfus Med Rev. 2000;14(2):151-60.